ABSTRACT -Circadian timing largely modifies efficacy of many medicinal drugs. This viewpoint has been applied in the clinical medicine, known as chronotherapy. We think this viewpoint should also be introduced into toxicology as "chronotoxicology", however, information about the diurnal variation in toxicant sensitivity is still very scarce. We present here a clear and reproducible diurnal variation of cadmium (Cd)-induced mortality in mice. Male ICR mice kept under standard condition (12 hr light/dark cycle, lights on at 08:00) were injected with CdCl 2 (7.2 mg/kg, one shot) intraperitoneally at different time points in the day (zeitgeber time (ZT) 0, 4, 8, 12, 16 or 20). Survival number was determined at 14 days after injection. Interestingly, mice were sensitive to Cd acute toxicity at ZT8, while tolerant at middark to early-light phase (ZT16, ZT20 and ZT0). Hepatic GSH level showed small daily fluctuation, lowest at ZT8 and highest at ZT20, and this fluctuation was similar to the diurnal variation of Cd sensitivity. In contrast, hepatic metallothionein (MT) level was not significant in these time points, although their level also showed small daily fluctuation. Our results indicated that Cd-induced mortality had clear diurnal variation, and suggested that the hepatic GSH level was one of the important factors for determination of this Cd-induced diurnal mortality.
INTRODUCTION
Cadmium (Cd) is used in various industrial products such as electrodes in Ni-Cd batteries, pigments (Cd-yellow), coatings for machinery parts, and alloys/control rods for nuclear reactors. Although the incidence of serious poisoning caused by occupational Cd exposure has declined due to improvements in the work environment, accidental or long-term exposure to Cd needs to be addressed. Therefore, Cd is a metal that should be attracted attention to researchers in occupational health even today (Miura, 2009) . Likewise, Cd toxicity is also addressed in public health, because Cd is a principal environmental toxicant that usually finds its way into the ecosystem as a result of human activities as mentioned above.
Cd is classified as a human carcinogen (Wade et al., 1993; Pinot et al., 2000) . In mammals, Cd exposure leads to renal and testicular damages, neuronal disorders, and respiratory diseases (Waalkes et al., 1992) . Many reports indicate that Cd induces a multiple array of cellular events such as cell cycle arrest (Xie and Shaikh, 2006; Bork et al., 2010) , oxidative stress (Cuypers et al., 2010; Matovic et al., 2011) , and enzyme inactivation (Chernyak et al., 1985; Paier et al., 1993) . Acute cadmium exposure shows hepatotoxicity that involves several biological pathways. One of the pathways is binding of Cd to sulfhydryl groups on critical biological molecules, especially in mitochondria, since Cd has a strong affinity for thiol groups (Rikans and Yamano, 2000) . Intracellular factors which possess thiol groups including glutathione (GSH) and metallothionein (MT) show protective capacity against Cd-mediated hepatotoxicity (Chan and Cherian, 1992) . MT is a cysteine-rich protein with high affinity for heavy metals. The main physiological roles of MT protein are detoxification of heavy metals, scavenging of free radicals, and maintenance of homeostasis of trace elements such as zinc and copper (Palmiter, 1998; Vasak and Hasler, 2000) . MT protein is induced by Cd exposure at transcriptional level, and takes part in detoxification of Cd (Kägi, 1993; Haq et al., 2003) . GSH is a ubiquitous sulfhydryl-rich tripeptide. Its physiological functions have been implicated in a variety of important cellular functions; GSH serves not only as an intracellular sulfhydryl buffer and reductant but also plays a role in the metabolism and transport of endogenous or exogenous compounds (Meister, 1984) . GSH also possesses protective role of cells against oxidative stress, radiation, and numerous toxic compounds (Jensen and Meister, 1983; Meister, 1984) . GSH provides a first defense line against Cd toxicity before induction of MT synthesis occurs (Singhal et al., 1987) . It is well known that biological responses to variety of drugs used to antitumor, antiangiogenic, antiasthma or antihypertensive show 24-hr rhythmicity (Peters et al., 1987; Koyanagi et al., 2003; Hermida et al., 2005; Burioka et al., 2010) , investigating administration timing influences the effects of these drugs. This diurnal variation may depend on alterations in drug metabolism activities, e.g. bioactivation or bioinactivation by cytochrome P450 enzymes, and has been applied as chronopharmacology and chronotherapy in the clinical medicine field (Burioka et al., 2010) . While the diurnal variations of drug sensitivities have often been demonstrated, the toxicological viewpoint that toxicity against exogenous material(s) especially heavy metals has diurnal variation (Cambar et al., 1983 ) is still scarce. We believe this viewpoint should be introduced into toxicology as "chronotoxicology" becoming indispensable in the future toxicology.
Many reports indicate that GSH levels in plasma and liver show the daily variation (Jaeschke and Wendel, 1985; Blanco et al., 2007) . Further, expressions of many drug processing genes show diurnal variation (Zhang et al., 2009) . We predict that toxic severity caused by heavy metal exposure is different when quantitative changes of the protective factors occurs; e.g., toxicity will arise strongly when biological defense functions are low (for their levels and/or activities). To prove this, we investigated the diurnal variation of cadmium-induced mortality using mouse model, as a result, we showed a clear diurnal variation of Cd-induced mortality.
MATERIAL AND METHODS

Animals and treatment
Male ICR mice (6 week of age; 35-40 g body weight) were purchased from Nihon Clea (Clea Japan, Inc., Tokyo, Japan). Mice were kept under standard conditions with controlled temperature (24 ± 1°C), humidity (55 ± 5%) and light (12:12 hr light/dark cycles, lights on at 08:00 hr). The lights were white fluorescent lamp, about 100-150 lux intensity at the level of cages. All animals had free access to sterilized commercial pellet diet (CE-2, Clea Japan, Inc., Tokyo, Japan), and sterilized filtered tap water.
For mortality assay, male ICR mice adapted for 7 days with assigned to 6 groups of 5 animals were administrated intraperitoneally (i.p.) with cadmium chloride (CdCl 2 , Wako chemical, Tokyo, Japan) at 6 different time points (clock time; 08:00, 12:00, 16:00, 20:00, 24:00, or 4:00), describing as zeitgeber time (ZT); ZT0, ZT4, ZT8, ZT12, ZT16, or ZT20. In case of dark period (ZT12, ZT16 and ZT20), administrations were done under red light. The mortalities were monitored until 14 days after the injection.
For analysis of diurnal variations of biological defense factors, male ICR mice which had not been received any administrations were dissected under ether anesthesia at 6 different ZT (0, 4, 8, 12, 16 and 20) , same time points as Cd-induced mortality test. Blood samples were collected from inferior vena cava using Supercath (Medikit Co. ltd., Tokyo, Japan) which needle was pre-saturated with heparin, and were centrifuged at 1,000 x g (4ºC, 10 min) to separate plasma samples. Liver samples were removed after saline perfusion followed by flash frozen in liquid nitrogen. All samples were stored at -80°C until analysis. These experiments were conducted under the guidelines for the care and use of laboratory animals set forth by our Institutional Animal Care and Use Committee of the National Institute of Occupational Safety and Health.
Hepatic GSH and MT and levels
For determination of hepatic GSH levels, liver samples were homogenized in 5% sulfosalicylic acid (SSA) for 30 sec in ice-water bath. The homogenates consisting of 100 mg liver in 1 ml (10%) were centrifuged at 8,000 x g for 10 min at 4°C to remove proteins. Supernatants were assayed for GSH using GSSG/GSH Quantification Kit (Dojindo Laboratories, Kumamoto, Japan) according to the manufacture's instruction.
Hepatic MT protein levels were determined by Hgbinding assay (Kobayashi et al., 2007) . Mercury bound to MT was measured using a mercury analyzer RA-2A (Nippon Instruments, Tokyo, Japan). The MT content was expressed as nanomoles of mercury bound.
Statistical analysis
All data were presented as the mean ± S.D. Statistical analyses were performed by ANOVA. Post-hoc TukeyKramer's multiple comparisons tests in a one-way ANO-VA were employed to show which time points (ZT) were significantly different within each experimental group. P-values lower than 0.05 were considered evidence for statistical signifi cance.
RESULTS
Diurnal variation of Cd-induced mortality
First, we determined the approximate half lethal dose of CdCl 2 at ZT4, simply a suitable time for experimenter. Male ICR mice (n = 5) were injected with various doses of CdCl 2 (4.2, 5.5, 7.2, or 9.3 mg/kg) intraperitoneally (i.p.) at ZT4. The survival number was estimated at 14 days after the injection. As a result, CdCl 2 of which mice were injected over the dose of 7.2 mg/kg killed about half the number of animals: for 7.2 mg/kg injection, 2 mice death; for 9.6 mg/kg injection, 4 mice death; therefore, we examined the next experiment, the diurnal variation of Cd-induced mortality, using the dose of 7.2 mg/kg.
Male ICR mice divided into six groups (n = 5) were injected i.p. with 7.2 mg/kg of CdCl 2 at different time points (ZT0, 4, 8, 12, 16 or 20) . The survival number determined at 14 days after the injection was shown in Fig. 1 . Interestingly, mice were sensitive to Cd acute toxicity at mid-to late-light phase (ZT4 and ZT8); this seemed to be time dependently, and conversely, mice were tolerant either at dark phase (ZT12 to ZT20) or early-light phase (ZT0) (Fig. 1, Exp-1) . In an additional experiment (n = 10), we also observed the highest mortality at ZT8, moreover, the lower mortality at mid-dark to early-light phase (ZT16, ZT20 and ZT0) (Fig. 1, Exp-2) . As for ZT12, the opposite result came out in two experiments. We thought this time was change of the lighting so that suffer stress might be given for the animals. Totally, our data showed that Cd-induced mortality had clear diurnal variation.
The survival curve for ZT8 and ZT20 in Exp. 2 ( Fig. 1 ) was drawn in Fig. 2 . Apparently, the survival number was more rapidly reduced in "sensitive" time (ZT8), compared with "tolerant" time (ZT20). Body weights (bw) at each injection time point were almost the same (Fig. 3-A) , however, the bw changes after injection were signifi cantly different; bw of the injection group at ZT8 was signifi cantly lower than other groups (Fig. 3-B) . The mice injected at "tolerant" time-periods had been moving actively and had shiny fur (subjective data). The mice which bw had been gradually recovered did not die over 20 days after injection, therefore they were thought to be survived from Cd toxicity. mice kept under standard condition (12 hr light/dark cycle, lights on at 08:00) were adapted for 7 days with assigned to 6 groups of 5 or 10 animals followed by injection with CdCl 2 (7.2 mg/kg) intraperitoneally at 6 different time points (ZT0, 4, 8, 12, 16, and 20) . Survival number was determined at 14 days after the injection. Two experimental result was given as Exp-1 (n = 5) and Exp-2 (n = 10). The time is represented as zeitgeber time (ZT), with ZT0 being 8:00 A.M.
Diurnal fl uctuation of hepatic GSH and MT levels
Changes in daily levels of biological defense factors were thought to be taken part in the diurnal variation of Cd-induced mortality. To prove this, we estimated the daily levels of GSH in liver of non-treated mice. The hepatic GSH level was lowest at ZT8 and highest at ZT20 (Fig. 4-A) . This daily fl uctuation seemed to be correlated to the pattern of Cd-induced diurnal mortality (Fig. 1), i.e., low GSH and high mortality at ZT8, and the opposite of which observed at ZT20.
The hepatic level of MT protein, another important defense factor against Cd toxicity, was highest at ZT12 and lowest at ZT0 (Fig. 4-B) . This daily fluctuation of basal hepatic level was not correlated to the Cd-induced diurnal mortality pattern. As a result, we conceived the "basal level" of MT was not involved in the expression of diurnal variation of Cd-induced mortality. These results suggested that the hepatic GSH level was one of the important factors for determination of Cd-induced diurnal mortality.
DISCUSSION
In this study, we demonstrated that ICR mice showed clear diurnal variation of Cd-induced mortality. CdCl 2 is a simple compound, thus enzyme like cytochrome P450 does not participate in the Cd metabolism. Therefore one of the causes of this diurnal variation is thought to be the difference in Cd accumulation (uptake and excretion) in the liver. Examination about this point is now in progress. Other causative factor is thought to be the difference in the biological levels (or activities) of biological protection factors against Cd toxicity. In our experiments, mice were sensitive to Cd-induced mortality at ZT8 (light phase) while tolerant at around ZT20 (dark phase) (Fig. 1) . Likewise, the hepatic GSH level was lowest at ZT8 and highest at ZT20 (Fig. 4-A) . GSH are thought to provide a fi rst defense line against Cd toxicity (Singhal et al., 1987) , further, GSH levels in plasma and liver show the daily variation (Jaeschke and Wendel, 1985 ; Blanco et al., 2007). Therefore, our result suggested that the lower hepatic GSH brought on the higher Cd-induced mortality. In order to confirm the participation of GSH, an examination of hepatic GSH depression using buthionine sulfoximine, a specific inhibitor of glutamate-cysteine ligase (Griffith et al., 1979) , is now in progress. Wimmer et al. (2005) reported two major branches of cellular anti-Cd defense, one via GSH and another one via metal-responsive transcription factor 1 and its target, MT. Although our data showed weak daily fluctuation of basal hepatic MT level (highest at ZT12 and lowest at ZT0; Fig. 4-B) , this daily fluctuation of basal hepatic level was not correlated to the Cd-induced diurnal mortality pattern. Therefore, we conceived the "basal level" of MT was not involved in the expression of diurnal variation of Cd-induced morality. Further examination is necessary to confirm the participation of MT using MT knockout mice.
The biological rhythm like a daily fluctuation is generated by the molecular circadian clocks. Cellular circadian clock is constituted of interconnected regulatory loops involving over 10 clock genes such as Bmal, Clock, Per, or Cry (Ko and Takahashi, 2006; Dardente and Cermakian, 2007) . These clock genes display circadian rhythms and drive the self-regulatory interaction of various gene and protein amounts (Levi and Schibler, 2007) . Recently, Esquifino et al. reported chronic Cd administration decreased expression of clock genes, Per 1 and Per 2, and prevention effect of melatonin on this reduction (Cano et al., 2007; Jimenez-Ortega et al., 2011) . Melatonin is the major secretory product from the pineal gland, which is released daily during night time. The one of the important physiological roles of melatonin is free radical scavenging (Hardeland et al., 2011) . Melatonin also restored Cd-induced hepatotoxicity in rat (Kim et al., 1998; El-Sokkary et al., 2010) . These reports have given some suggestion to us; melatonin is one of the determination factors for diurnal variation of Cd-induced mortality, since its maximal blood level is at mid-to late-dark phase and its ability as an antioxidant. It seems that these facts are as parallel as our present data which Cd gave less mortality at mid-to late-dark phase.
In conclusion, we presented here that Cd-induced mortality had clear diurnal variation, and suggested that the hepatic GSH level was one of the important factors for determination of this Cd-induced diurnal mortality.
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